Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.
Articles from the journal in Anti-Cancer Agents in Medicinal Chemistry, 16 issue 1:
- Therapeutic Use of MicroRNAs in Cancer
- The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101
- Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
- Targeting Cancer Stem Cells: Promises and Challenges
- CXCR4 and Glioblastoma
- Therapeutic Potential of Targeting PAK Signaling
- Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
- The Immune System in Cancer Prevention, Development and Therapy
- Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids
- Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
For details on the articles, please visit this link: http://bit.ly/1ljMCpv
SMi’s 13th annual Controlled Release conference will enable you to engage in discussions with industry leaders to discover the latest innovations, as well as guiding you through the latest regulatory updates to ensure strict compliance. The two-day programme will also address up-and-coming novel controlled release strategies to accelerate commercialisation with case studies from GSK, Merck, UCB, Astra Zeneca, Critical Pharmaceuticals, Novo Nordisk, Lundbeck, Diurnal, Ipsen, MedImmune, MHRA and more.
For further information and to register, visit http://www.controlledrelease.co.uk/benthamscience
This event is about the developments in the field of pharmaceutical Microbiology. Pharmaceutical microbiology is crucial to the manufacture and production of drugs, biologics and devices. Without a strong understanding of the process from case studies and learning from mistakes it can be incredibly costly.
Set to take place in Central London on the 20th-21st January 2016 the 5th annual pharmaceutical microbiology will once again be bringing together industry leaders and key figures in the field to discuss and develop a greater understanding of key issues and regulations.
The Challenge of a “Functional Cure” for AIDS by Gene Modified HSCT Therapy is the article from the journal Current Stem Cell Research & Therapy , 10(6): 492-498,
Abstract: Acquired immunodeficiency syndrome (AIDS), an infectious disease which is difficult to be cured, is regularly and effectively treated with anti-retroviral therapy in clinic. When considering about the defects of antiretroviral therapy (ART), patients need a new way to cure AIDS. With the development of genetic engineering technology and humanized mouse models, a new way has been found to achieve a “functional cure” for AIDS.
Food Addiction Spectrum: A Theoretical Model from Normality to Eating and Overeating Disorders
Author(s): Armando Piccinni, Donatella Marazziti, Federica Vanelli, Caterina Franceschini, Stefano Baroni, Davide Costanzo, Ivan Mirko Cremone, Antonello Veltri and Liliana Dell’Osso
Abstract: The authors comment on the recently proposed food addiction spectrum that represents a theoretical model to understand the continuum between several conditions ranging from normality to pathological states, including eating disorders and obesity, as well as why some individuals show a peculiar attachment to food that can become an addiction. Further, they review the possible neurobiological underpinnings of these conditions that include dopaminergic neurotransmission and circuits that have long been implicated in drug addiction. The aim of this article is also that at stimulating a debate regarding the possible model of a food (or eating) addiction spectrum that may be helpful towards the search of novel therapeutic approaches to different pathological states related to disturbed feeding or overeating.
– See more at: http://www.eurekaselect.com/node/128902/article
See more articles categorized by diseases in the tab ‘Articles by Disease’ on our website www.benthamscience.com
Article: “An Overview of the Modulatory Effects of Oleic Acid in Health and Disease”
Evidences in the last years have showed the effects of oleic acid (OA) in human health and disease. Olive oil, rich in oleic acid, is supposed to present modulatory effects in wide physiological functions, while some studies also suggest a beneficial effect on cancer, autoimmune and inflammatory diseases, besides its ability to facilitate wound healing. Read more about this article here: http://bit.ly/1KYBh2R